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Abstract
Introduction: The aim of this study was to investigate the role of hand bone mineral density (BMD) loss analyzed
with digital X-ray radiogrammetry (DXR) in early rheumatoid arthritis (RA) as a predictor for progression of joint
damage.
Methods: In 379 patients with early RA, baseline and one-year hand BMD was measured with DXR and the hand
bone loss (HBL) was analyzed using the smallest detectable change (HBLsdc) and tertiles (HBLtertiles). Joint
damage in hands and feet were scored according to the Sharp van der Heijde (SHS) method at baseline and at
one, two, five and eight years. At the same time-points Disease Activity Score (DAS28) was calculated and
functional disability assessed. Rheumatoid factor (RF) and antibodies against cyclic citrullinated peptides (anti-CCP)
were analyzed at baseline.
Results: Sixty-six percent of the patients had hand BMD loss in the first year of RA determined by HBLsdc and 65%
by HBLtertiles. Radiographic progression after two, five and eight years was associated with hand bone loss
defined by HBLsdc. By HBLtertiles there were significant associations at all time-points except at eight years. The
change in DXR at one year (ChDXR1yr) correlated significantly and inversely with the change in SHS (ChSHS) at two,
five and eight years. Multivariate analysis showed that only change in SHS during the first year and the presence of
anti-CCP were independent predictors of long-term progressive joint damage. If radiographic scores were not
included, DXR-BMD loss was an independent predictor. Patients with great bone loss by HBLtertiles had
significantly more often high disease activity after two years. However, neither bone loss by HBLsdc or HBLtertiles
nor by ChDXR1yr was an independent predictor of remission after two, five and eight years.
Conclusions: This study confirms previous reports of an association of decrease in DXR-BMD during the first
disease year with progression of radiographic joint damage over an extended period of time. This association was
independent in a regression model only when radiological findings were excluded suggesting a possible predictive
role of DXR-BMD in clinical practice when radiographic evaluation is not available. However, further studies are
required before this can be established.
Introduction
Rheumatoid arthritis (RA) is a progressive autoimmune
disease characterized by inflammatory activity in the
joints, synovial sheets of tendons and bursae as well as
extra-articular manifestations such as vasculitis and ser-
ositis [1-3]. The increased amount of pro-inflammatory
cytokines mediates osteoclast activation, which in turn
provokes joint destruction [4].
Both the disease and its drug treatment can cause sys-
temic bone loss and also a periarticular disease-related
osteoporosis [5]. The periarticular bone loss in hands is an
early feature of RA and may precede erosions [6,7]. As
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periarticular demineralization and joint damage are both
related to imbalance in osteoclast and osteoblast activity,
measures of hand bone loss may be a marker for active
deterioration of bone and a predictor of subsequent erosive
joint damage.
Radiogrammetry was introduced in the sixties for
assessment of skeletal status, using various measures of
the cortical bone on conventional hand radiographs.
The diaphysis of the second metacarpal of the hand was
often selected for radiogrammetry. Measurements of the
total and medullar width of the bone can be used to cal-
culate different indices and to consecutively quantify
changes of cortical bone [8].
The availability of digital images provides the opportu-
nity for quantitative measurements of radio-geometric
features and offers a refinement for radiogrammetry
[9,10]. Digital X-ray radiogrammetry (DXR) is a techni-
que that uses automated image analyses of standard hand
radiographs, either in digital or conventional analog for-
mat, to estimate bone mineral density (DXR-BMD)
[8,11,12]. DXR was first introduced into clinical practice
in 1999 for osteoporosis assessment. Several studies have
shown that this technique has a potential to predict pro-
gressive joint damage in RA [13-15].
The heterogeneity of the RA disease and the need for
rapid adjustment of disease management puts high
requirements on markers for disease progress. The cur-
rently available predictors for poor outcome are not per-
fect and there is a need for improved decision support.
The aim of this study was to investigate the potential of
hand BMD loss analyzed with DXR to predict progression




BARFOT (Better Anti-Rheumatic FarmakOTherapy) is a
multicenter observational study (six centers in southern
Sweden) of patients with recent (disease duration < one
year) onset RA satisfying the 1987 American College of
Rheumatology (ACR) classification criteria [6]. Eight
hundred and thirty nine (839) patients were consecutively
enrolled into the BARFOT study [16] between 1993 and
1999. The patients were between 18 and 80 years of age.
The present study comprised the 379 patients who had
radiographs available at baseline and one-year follow up,
which were suitable for DXR-BMD measurement. Of
those with accessible and readable radiographs, four
patients were excluded due to improper positioning of
the hand. During the observation period, patients were
treated according to clinical judgment by their rheuma-
tologist, except for 166 patients participating in a rando-
mized low-dose glucocorticoid study [17].
Radiographic evaluation
Radiographs of hands and feet were taken at study entry
(baseline) and after one, two, five and eight years. At two
years radiographs were available for 355 patients, at five
years for 288 patients and at eight years for 240 patients.
Radiographic damage was scored according to the Sharp
van der Heijde score (SHS) [18] which includes hands
and feet. A total SHS range 0 to 448, consisting of ero-
sion score (E score) range 0 to 280 and joint space nar-
rowing score (JSN score) range 0 to 168. An increase of 1
unit means one new pathologic change - E or JSN. Two
trained readers, who were blind for treatment and clinical
data, read the films in chronological order.
Radiographic progression was defined as a SHS above
the smallest detectable change (sdc), which was 5.8, cal-
culated by the formula described by Bruynesteyn et al.
[19].
Hand BMD measurements
BMD of the hands was measured by applying DXR, at
baseline and after one year, to the same radiographs of
hands that were used for radiographic scoring. The analo-
gue X-ray films were digitized using a Vidar Diagnostic
Pro plus, 300 dpi, 12 bit (VIDAR Systems Corp., Herndon,
VA, USA). DXR-BMD was measured on the digitized
images by dxr-online (Sectra, Linköping, Sweden). DXR is
a computerized version of the traditional technique of
radiogrammetry [20]. The technique has been described in
detail previously [8,21]. In short, this method provides a
BMD estimate in g/cm² based on an automated analysis of
the geometry and texture of the cortical bone of the three
middle metacarpals.
When radiographs for both hands were available, the
mean BMD was used in the analyses to maximize accuracy
of the BMD loss measurement.
Hand bone loss
Hand bone loss (HBL) was defined as present or not pre-
sent if the one year change in DXR-BMD was more than
0.0048 g/cm² (4.8 mg/cm²), the smallest detectable
change (sdc) [21] or not (HBLsdc) and as great, moderate
or no/small if the one year change in DXR-BMD was
within the upper, medium or lower tertiles (HBLtertiles).
Changes in HBL are calculated in relation to baseline
values.
Clinical evaluations
Clinical assessments were performed at baseline, three and
six months, and one, two, five and eight years. Disease
activity was assessed by the Disease Activity Score calcu-
lated on 28 joints (DAS28) [22]. High disease activity is
defined as a DAS28 >5.1, moderate >3.2 ≤5.1 and low ≤3.2
[23]. The European League against Rheumatism (EULAR)
definition of remission, a DAS28 <2.6, was used [24].
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Acute phase reactions were measured by erythrocyte sedi-
mentation rate (ESR, mm/h) and C-reactive protein (CRP,
mg/L), according to standard laboratory methods. Patients’
estimated general health (GH) was assessed by a 0 to 100
mm horizontal visual analogue scale (VAS) where 0 is best
and 100 worst.
Rheumatoid factor (RF) and antibodies against cyclic
citrullinated peptides (anti-CCP) were analyzed at base-
line. Functional disability was assessed using the Swedish
version of the Stanford Health Assessment Questionnaire
(HAQ) [25]. The HAQ score ranges from 0 to 3, where a
higher score indicates a higher degree of disability.
Statistics
Statistical analyses were performed using SPSS version
17.0 statistical software. All significance tests were two-
tailed and conducted at the 0.05 significance level. To test
the differences between groups, the Mann-Whitney U-test
or the independent t-test was used for continuous vari-
ables, and the chi2-test for proportions. The Wilcoxon
matched pairs test was used to compare changes of a vari-
able over time. Spearman’s correlation test was used to
assess the relationships between two continuous variables.
The inter- and intra-observer reliability was assessed by
the intra-class correlation coefficient (ICC) (absolute
agreement, two-way mixed model) for status and change
scores at baseline and two years.
Univariate analyses were performed by score tests and
multiple logistic regression analyses were performed
including variables with a statistical significance in the
score test of p < 0.1.
Ethics committees
All patients gave their informed consent and the ethical
committees in Göteborg: Gbg Ö 282-01; Lund: LU 398-
01; Linköping: LI 01-263; Karolinska Institutet: KI 02-075
approved the study.
Results
Baseline characteristics of the patients
Demographic and clinical characteristics at baseline for
the participating 379 patients are shown in Table 1. Fifty-
seven percent of the patients had no erosions at baseline.
There were no significant differences in baseline char-
acteristics between these 379 patients having and the 460
patients lacking radiographs suitable for DXR-analyses at
baseline and one year (data not shown).
DXR - BMD
At baseline, the mean (SD) DXR-BMD was 574(94) mg/
cm² and the mean (SD) Z-score -0.10 (1.13). The mean
(SD) change in DXR-BMD from baseline to one year
(ChDXR1yr) was -16 (19) mg/cm² (-1.3 mg/cm²/month)
and mean (SD) change in Z- score was -0.27(0.35). A
cumulative probability plot illustrates ChDXR1yr (Figure 1).
Figure 1 shows that the lower tertile corresponds to a one
year change in BMD of -5 and the upper a change of
-18 mg/cm².
Correlations between decreased DXR-BMD and increased
radiographic damage scores
ChDXR1yr correlated significantly and inversely with ChSHS
at two, five and eight years with the correlation coefficients
-0.295, -0.215 and -0.239, respectively, all p < 0.001.
Hand bone loss was associated with increase in
radiographic damage score
The mean ChSHS at two, five and eight years was at all
time-points significantly greater in the group of patients
with hand bone loss by HBLsdc. The association was
most pronounced at two years (Table 2).
Similarly, the mean ChSHS at these time points was
significantly greater in patients with hand bone loss
according to HBLtertiles. A post hoc pair wise analysis
showed that, at two years, the groups of patients with
great and moderate HBL had significantly greater
ChSHS than the group with no/small HBL while at five
and eight years this was the case only for the great HBL
group (Table 3).
Table 1 Demographic and baseline clinical characteristics
for the 379 patients.
Mean (SD) Number (%)
Age at inclusion, years 57 (15)
Disease duration, months 6.3 (3.2)
Women 241 (64)
Anti CCP positive 210 (61)
RF positive 221 (65)
DAS28 5.07 (1.2)
ESR 38 (26)
CRP, mg/L 37 (38)
HAQ, 0-3 0.97 (0.61)
Total Sharp score (SHS) 4.0 (8.2)
Erosion score (ES) 1.7 (3.8)
Joint space narrowing score (JSN) 2.3 (5.2)
Prednisolone 1876 (50)
DMARDS None 77 (20)
Methotrexate 155 (41)
Sulfasalazine 102 (27)
Other DMARD 44 (12)
Combination 1 (0)
Biologics 0 (0)
Anti-CCP, antibodies against cyclic citrullinated peptides; CRP, C-reactive
protein; DAS28, Disease Activity Score calculated on 28 joints; DMARDS,
disease modifying anti-rheumatic drugs; ESR, erythrocyte sedimentation rate;
HAQ, Health Assessment Questionnaire; N, number; RF, rheumatoid factor; SD,
standard deviation.
Forslind et al. Arthritis Research & Therapy 2012, 14:R219
http://arthritis-research.com/content/14/5/R219
Page 3 of 9
The differences in mean ChSHS over time between the
groups of patients with HBLsdc and HBLtertiles are illu-
strated in Figures 2 and 3.
Hand bone loss was associated with radiographic
progression
Radiographic progression from baseline was seen in 25%
of the patients after one year, in 41% of the patients at the
follow-up visit at two years, in 60% at five years and in
61% at eight years.
At the same time-points 43%, 38%, 37% and 36% of the
patients, respectively, still had no erosions. The inter- and
intra-observer reliability was 0.94 and 0.99, respectively.
Radiographic progression after two, five and eight years
was associated with HBL defined by HBLsdc (Table 4).
By HBLtertiles there were significant associations at all
time-points except at eight years (Table 5). The associa-
tion was most pronounced after two years, when 49% of
the patients with HBL by HBLsdc had radiographic pro-
gression and analyzed by HBLtertiles also 49% (54% of
the patients with great and 44% with moderate HBL) had
radiographic progression (p < 0.001).
The performance of DXR-BMD as a predictor of
radiographic progression
Univariate analyses by score tests of demographic and
clinical variables possibly associated with radiographic
progression were performed. Since the predictive ability of
a change in DXR-BMD over one year is under study, not
only baseline data but also information obtained up to one
year after baseline could have useful predictive value and
must, therefore, be taken into consideration. The following
variables were univariately associated with radiographic
progression, at two, five and eight years: ChDXR1yr,
HBLsdc, HBLtertiles, ChSHS1yr, presence of erosionsbl,
anti- CCP as well as number of swollen joints1yr; at
two years: DAS281yr, GH1yr, ESRbl, ESR1yr, HAQ1yr and
CRP1yr ; at five years: DAS281yr, ESRbl, ESR1yr, CRP bl, and
CRP1yr ; and at 8 years: tender jointsbl and tender joints1yr .
Age, disease duration, gender, smoking, baseline disease-
modifying anti-rheumatic drug (DMARD) and glucocorti-
coid treatment as well as baseline DXR-BMD (including Z
scores) were not univariately associated with radiographic
progression at any time point.
The positive predictive values (PPVs) of the presence of
HBL by HBLsdc for radiological progression at two, five
and eight years (prevalence of 41%, 60% and 61%, respec-
tively) were 49%, 65% and 61%. The corresponding PPVs
of anti- CCP were 50%, 73% and 70%; of erosionsbl 56%,
73% and 73%; and of ChSHS1yr (above median) were 76%,
81% and 83%.
ChDXR1yr and the other variables significantly asso-
ciated with radiographic progression in the univariate
analysis were put into multiple logistic regression ana-
lyses with radiographic progression at two, five, and eight
years as dependent variable. Table 4 shows the two-year
result where ChSHS1yr and anti-CCP proved to be inde-
pendent predictors of radiographic progression which
also was the result for five years. At eight years ChSHS1yr,
anti-CCP and the number of tender jointsbl and tender
joints1yr were independent predictors.
Since scoring of radiographs is infrequently performed
in clinical practice, models excluding radiographic scores
(ChSHS1yr) were also done. Then ChDXR1yr indepen-
dently predicted radiographic progression at two years in
addition to anti- CCP, number of swollen joints1yr and
presence of erosionsbl (Table 6). In the prediction models
at five and eight years ChDXR1yr did not attain statistical
significance (p = 0.083 and 0.073, respectively). At five
years, erosionsbl, anti-CCP, number of swollen joints1yr,
and CRP1y, were independent predictors and at eight
years anti-CCP, number of swollen joints1yr and number
of tender joints at baseline and one year.
HBLsdc and HBLtertiles were univariately associated
with radiographic progression at all time-points, but did
not significantly contribute to prediction in the multi-
variate models (data not shown).
Table 2 Change in radiographic scores (SHS) in presence
or absence of hand bone loss.
HBLsdc
No hand bone loss Hand bone loss Diff.
Change in SHS Mean SD N Mean SD N p
ChSHS2yr 4.31 8.36 113 10.81 15.48 242 0.001
ChSHS5yr 11.82 15.36 89 21.49 26.59 199 0.003
ChhSHS8yr 13.31 16.91 81 23.58 28.34 159 0.005
ChSHS, change in SHS; HBLsdc, hand bone loss smallest detectable change; N,
number; SD, standard deviation; SHS, Sharp van der Heijde Score; yr, year.
Figure 1 Cumulative percent plot of the change (mg/cm2) in DXR
from baseline to one year. Reference lines denote tertiles -upper
tertile- a change of -18 mg/cm²; lower tertile - a change of -5 mg/cm².
DXR, digital X-ray radiogrammetry.
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The best model predicting radiographic progression was
obtained at the two- year follow-up visit. In this model,
including radiographic scores Nagelkerke R2 was 77% and
91% of the patients correctly classified while the corre-
sponding figures were 36% and 75% in the model exclud-
ing radiographic scores (Table 6). After five years, R2 was
52% and 38% and the proportion of correct classifications
was 79% and 75% in the models with and without radio-
graphic scoring, respectively. The corresponding figures
for eight years were 44% and 30% and 73% and 72%,
respectively.
Replacing ChDXR1yr with Z-scores to account for age
related bone loss did not improve prediction (data not
shown).
DXR -BMD and clinical outcome
Hand bone loss and degree of disease activity after two,
five and eight years
Cross tabulation of hand bone loss by HBLsdc and
degree of disease activity showed no significant differ-
ences in degree of disease activity after two, five and
eight years in patients with or without bone loss (data
not shown). However, patients with great bone loss by
HBLtertiles had significantly high disease activity more
often after two years compared with patients with mod-
erate or low activity (16% versus 5% and 6%, respec-
tively, p = 0.009).
Hand bone loss and remission
In patients with HBL by HBLsdc, remission was signifi-
cantly less frequent after two years than in patients
without (38% versus 49%, p = 0.037) but not after five
(43% versus 39%, p = 0.49) or eight years (40% versus
48%, p = 0.24).
In patients with great bone loss by HBLtertiles, remis-
sion was less frequent after two years than in patients
with moderate or no/small bone loss (34% versus 41%
and 50%, respectively, p = 0.045). No significant differ-
ences were seen after five years (42% versus 46% and
39%, respectively, p = 0.59) or eight years (36% versus
46% and 47%, respectively, p = 0.27.)
Hand bone loss as a predictor of remission aftertwo, five
and eight years
Although DXR-BMD showed a univariate association
with remission at two and eight years, neither bone loss
by HBLsdc or HBLtertiles nor by ChDXR1yr was an
independent predictor of remission after two, five and
Table 3 Change in radiographic scores (SHS) in patients with great, moderate or no/small hand bone loss.
HBLtertiles
Great bone loss Moderate bone loss No/small bone loss Diff.
Mean SD N Mean SD N Mean SD N p
Change in SHS
ChSHS2yr 12.84 18.74 119 8.90 11.33 118 4.44 8.37 118 0.001
ChSHS5yr 23.96 29.64 103 19.03 23.09 91 12.01 15.32 94 0.005
ChSHS8yr 26.04 30.65 81 21.17 26.09 75 13.46 16.74 84 0.011
ChSHS, change in SHS; HBL, hand bone loss; N, number; SD, standard deviation; SHS, Sharp van der Heijde Score; yr, year.
Figure 2 Radiographic progression, as change in SHS, over
eight years in patients with and without HBLsdc. SHS, Sharpe
van der Heijde score.
Figure 3 Radiographic progression, as change in SHS, over
eight years in patients with and without HBLtertiles. SHS,
Sharpe van der Heijde score.
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eight years in models including and excluding x-ray
scores (data not shown).
Discussion
In this study on 379 patients with early RA who were fol-
lowed for eight years we have studied the potential of
HBL during the first year measured by DXR to predict
radiographic joint damage progression after two, five and
eight years.
In accordance with previous studies, HBL above SDC
was significantly associated with radiographic joint
damage. This was the case also when HBL was defined by
tertiles as great, moderate or no/small.
In the early stage of the disease the patients had bone
loss more often than they had radiographic progression.
Thus, after one year HBL was present in 68% of the
patients while progressive joint damage was seen in only
25%. With time radiographic progression increased to
more than 60%, which is in agreement with the report by
Güler-Yüksel et al. [26], who showed bone loss after one
year in 68%, progressive joint damage in 18% and after four
years progressive joint damage in 30%. The explanation for
this difference is that localized loss of BMD predates ero-
sions and joint destruction [27,28].
Change in DXR-BMD between baseline and one year
correlated significantly and inversely with change in SHS
at all time-points. This is in agreement with previous stu-
dies [13,14,29]. In an observational study, Stewart et al.
showed that measurement of HBL over one year, using
DXR, correlated with erosive changes in patients with
early RA at four years follow-up [29] and Hoff et al. also
showed that patients with hand BMD loss at one year
had more radiographic damage at five and ten years in
comparison with patients without HBL [30]. However, in
these studies, the correlations between hand BMD and
joint damage were found to be small suggesting that the
predictive ability of HBL for joint damage may be limited.
This notion is further supported by the modest PPVs of
HBL for joint damage found in the present study.
The change in SHS from baseline to one year and the
presence of anti-CCP, but not change in DXR-BMD,
were the only independent predictors of radiographic
progression at two years. This is in line with the BeSt
study reporting that hand BMD loss as a risk factor for
further radiographic damage is largely overridden by
change in SHS measured over one year [26]. This implies
that the first year change in DXR-BMD does not add to
the therapeutic decision if radiographic scores are avail-
able. However, in clinical practice, scoring radiographs is
not frequently performed, as it is a time-consuming
method requiring special training.
Therefore, in the absence of radiographic scores, DXR-
BMD, which today may be easily accessible in clinical
practice, might be a helpful predictor. Indeed, the present
data show that in the absence of radiographic scoring the
change in DXR-BMD was an independent predictor of
radiographic progression, significant at two years, but not
at five and eight years.
In the present study, change in SHS over the first year
was the single best predictor of further radiological pro-
gression. This predictor attained the highest PPVs and
contributed highly to create the best regression model for
predicting radiological outcome at two years, in which also
the presence or absence of baseline erosions, anti-CCP
and number of swollen joints after one year were indepen-
dent predictors. By this model Nagelkerke R2 was 77% and
91% of the patients could be correctly classified. Thus,
change in SHS over the first year is indeed a promising
predictor for use at this stage of the disease. However, it
would be ideal if reliable predictors could be identified at
an earlier stage of the disease.
Ongoing studies including measuring changes in DXR-
BMD over shorter time periods, for example, three and six
months, are awaited with great interest. Recently a study
with six months data on hand BMD loss was published
[31]. Here DXR-BMD loss was measured from baseline to
six months in 80 patients with early (mean disease dura-
tion 11 month) undifferentiated arthritis. They found that
great BMD loss was associated with RA development after
one year. It should be noted that the cut-off value for
‘great bone loss’ was considerably higher than that used in
the present study (≥2.5 versus 1.5 mg/cm²/month).
It has been suggested that treatment with biologics
may decelerate the development of erosions more than
Table 4 Radiographic progression in presence or absence










2 years 27(24) 118(49) 0.001
5 years 43(48) 129(65) 0.008
8 years 42(52) 105(66) 0.033
HBLsdc, hand bone loss smallest detectable change; N, number.
Table 5 Radiographic progression in patients with great,











N (%) N (%) N (%) p
2 years 64(54) 52(44) 29(25) 0.001
5 years 72(70) 54(59) 46(49) 0.011
8 years 57(70) 46(61) 44(52) 0.060
HBL, hand bone loss; N, number.
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it reduces HBL [32]. However, since the present study
was performed before the introduction of biologics, this
issue could not be further addressed.
Loss of bone measured by HBLsdc and HBLtertiles was
more frequent in patients with high disease activity and in
patients not in remission after two years but not in later
phases of the disease. HBL did not come out as an inde-
pendent predictor of clinical outcome in multiple regres-
sion analyses. In 145 patients from the BeSt study, where
change in hand BMD by DXR was investigated, an
increase in BMD occurred mostly in patients with contin-
uous remission by the EULAR criterion [33]. However,
continuously low disease activity did not appear to provide
less loss in hand BMD than continuously high disease
activity. Therefore, although reduction of BMD is a conse-
quence of inflammation, DXR-BMD is not a suitable tool
for predicting disease activity in the future.
A shortcoming of this study was that, at several sites,
the technical conditions at acquisition of X-rays were
such that BMD could not be measured for some patients
which led to the loss of several patients from the study,
but the included patients did not differ in baseline char-
acteristics from those not included. Furthermore, the
patients with early RA in this study fulfilled the ACR
1987 criteria, whereas patients with very early RA who
presented with limited clinical symptoms were not
included until they fulfilled the criteria. This means that
we have no data, neither of radiographic damage nor of
bone mineral density from the very early phase of RA.
Conclusions
To conclude, the present study confirms previous studies
reporting an association of change in DXR-BMD over the
first year of RA disease with progression of radiographic
joint damage over an extended period of time. However,
the change in DXR-BMD was not an independent predic-
tor of radiographic joint damage progression. Instead,
change in SHS from baseline to one year was a strong pre-
dictor of radiographic progression both after two years
and after longer follow-up visits at five and eight years. On
the other hand, when radiological findings were excluded
the association was independent. This suggests a possible
predictive role of DXR-BMD in clinical practice when
radiographic evaluation is not available. However, since
the association was significant only after the follow-up at
two years and the PPVs of bone loss for radiological pro-
gression were quite small, further studies are required
before this can be established. Further studies on DXR
may focus on the diagnosis of early RA also considering
sex- and age-related DXR data that define a threshold
value to discriminate possible patients with RA. In particu-
lar, studies with a shorter interval between measurements
of DXR-BMD are encouraged to evaluate its predictive
power in early RA, ideally before joint damage has become
identified radiographically.
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Table 6 Multiple logistic regression of possible independent predictors of radiographic progression at two years.
Model with x- ray scoresa Model without x- ray scoresb
OR 95% CI p OR 95% CI p
Change DXR 1 yr 1.001 .0.974 1.029 .956 0.971 0.955 0.988 .001
Change SHS 1 yr 2.667 2.027 3.511 .000
Erosions at baseline .666 .262 1.691 .392 2.592 1.486 4.519 .001
Anti- CCP 3.475 1.332 9.066 .011 3.132 1.701 5.766 .001
Number of swollenjoints 1 yr 1.086 .931 1.267 .296 1.129 1.021 1.248 .018
DAS28 1 yr 1.220 .645 2.307 .541 1.181 .791 1.764 .417
General health 1 yr .990 .961 1.021 .527 .997 .979 1.016 .761
ESR baseline .999 .979 1.018 .886 .991 .979 1.004 .178
ESR 1 yr 1.014 .980 1.050 .415 1.005 .982 1.030 .665
HAQ 1 yr 1.327 .570 3.092 .512 1.079 .608 1.916 .795
CRP 1 yr .974 .929 1.020 .261 1.006 .980 1.032 .656
Constant .014 .000 .060 .001
aR2 = 77%. 91% correct classification. bR2 = 36%. 75% correct classification. Anti-CCP, antibodies against cyclic citrullinated peptides; CI, confidence interval; CRP,
C-reactive protein; DAS28, Disease Activity Score calculated on 28 joints; DXR, digital X-ray radiogrammetry; ESR, erythrocyte sedimentation rate; HAQ, Health
Assessment Questionnaire; OR, odds ratio; SHS, Sharp van der Heijde Score; yr, year.
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